Explore 3 Stock Ideas & Industry Insights Download Free Report

Announcements

Wartell Joins Fractyl Health Board, Reports Zero Holdings

Michael J. Wartell filed an initial statement of beneficial ownership (Form 3) with the SEC on November 6, 2026, disclosing his status as a newly appointed director of Fractyl Health, Inc. as of November 2, 2026.

Manish Choudhary | 06 November 2026

Peter Carter Sells 44,950 Delta Air Lines Shares at $89.287

Delta Air Lines President Peter W. Carter filed a Form 4 on November 6, 2026, disclosing the sale of 44,950 shares of Delta Air Lines common stock on November 4, 2026.

Anjali Anand | 06 November 2026

Kontoor Brands Closes Lee Brand Sale for $750 Million

Kontoor Brands, Inc. filed a Form 8-K on November 6, 2026, disclosing the completed sale of its wholly-owned subsidiary The H.D. Lee Company, Inc. to ABG-Storm LLC, an affiliate of Authentic Brands Group, on November 2, 2026.

Manish Choudhary | 06 November 2026

Alclear Investments Sells 176,096 YOU Shares in Nov 2026

Alclear Investments, LLC filed a Form 4 with the SEC on November 6, 2026, disclosing the sale of 176,096 shares of Clear Secure, Inc. Class A Common Stock on November 4, 2026, executed pursuant to a Rule 10b5-1 trading plan.

Manish Choudhary | 06 November 2026

Clear Secure CEO Seidman Becker Sells 176,096 Shares Nov 2026

Caryn Seidman Becker, Chief Executive Officer and 10% owner of Clear Secure, Inc. (NYSE:YOU), filed a Form 4 on November 6, 2026, disclosing the sale of 176,096 shares of Class A Common Stock on November 4, 2026, along with related unit exchanges completed on …

Anjali Anand | 06 November 2026

Gilead CEO O'Day Exercises 112,429 Options, Sells Shares

Daniel Patrick O'Day, Chairman and CEO of Gilead Sciences, Inc., filed a Form 4 on November 6, 2026, disclosing the exercise of non-qualified stock options and sale of common stock on November 4 and November 5, 2026, pursuant to a Rule 10b5-1 trading plan.

Manish Choudhary | 06 November 2026

Madrigal General Counsel Kelley Sells 1,077 Shares at $400

Shannon T Kelley, General Counsel of Madrigal Pharmaceuticals, Inc., filed a Form 4 on November 6, 2026, disclosing the sale of 1,077 shares of common stock at $400 per share under a pre-established Rule 10b5-1 trading plan.

Nitish Kishor | 06 November 2026

Bruce Cozadd Plans to Sell 68,808 Jazz Pharma Shares

Jazz Pharmaceuticals Public Limited Company director Bruce Cozadd filed a Form 144 notice on November 6, 2026, disclosing a proposed sale of 68,808 common shares on NASDAQ following a stock option exercise.

Anjali Anand | 06 November 2026

Everest Group Director Galtney Plans 7,500-Share Sale

Director William F. Galtney Jr. filed a Form 144 notice on November 6, 2026, disclosing a proposed sale of 7,500 shares of Everest Group, Ltd. common stock on the New York Stock Exchange.

Shwetambri Chauhan | 06 November 2026

Zaslav Plans Sale of 46,600 Grupo Televisa Series "A" Shares

David Zaslav, a director of Grupo Televisa, S.A.B., filed a Form 144 notice on November 6, 2026, proposing the sale of 46,600 Series "A" Shares of Grupo Televisa through J.P. Morgan Securities LLC on the New York Stock Exchange.

Manish Choudhary | 06 November 2026
Support

Hi! How can we help you today?

Loading…